NEW YORK (Reuters Health) - The results of a new study suggest that the combination of alcohol and an extended-release formulation of morphine does not increase the rate of absorption of the potent ...

Amneal to hold CREXONT launch symposium and scientific presentations at the International Congress of Parkinson’s Disease and Movement Disorders on Sept. 27 – Oct. 1, 2024 BRIDGEWATER, N.J.--(BUSINESS ...

Jornay PM (methylphenidate) is a prescription drug for treating attention deficit hyperactivity disorder (ADHD) in adults and some children. The drug comes as an oral capsule that’s taken once daily.

Qsymia (phentermine/topiramate) is a prescription drug approved for weight loss in adults and certain children. It comes as an extended-release oral capsule and is ...

The US Food and Drug Administration (FDA) has issued a complete response letter on a New Drug Application (NDA) from Impax Pharmaceuticals for an extended-release capsule formulation of ...

, today announced the presentation of results from its RYTARYTM (IPX066) Phase III and open-label extension trials at the 65th Annual Meeting of the American Academy of Neurology in San Diego, CA on ...

PARIS — Consistent with what is known about minoxidil pharmacokinetics, a controlled trial found that an investigational extended-release oral formulation of minoxidil provided more favorable hair ...